Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.10
+0.06 (0.85%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Precision BioSciences Employees
Precision BioSciences had 68 employees as of December 31, 2025. The number of employees decreased by 40 or -37.04% compared to the previous year.
Employees
68
Change (1Y)
-40
Growth (1Y)
-37.04%
Revenue / Employee
$503,882
Profits / Employee
-$672,412
Market Cap
183.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Tonix Pharmaceuticals Holding | 142 |
| Cartesian Therapeutics | 75 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 58 |
| Corbus Pharmaceuticals Holdings | 36 |
| Whitehawk Therapeutics | 23 |
| Unicycive Therapeutics | 22 |
DTIL News
- 22 hours ago - Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting - Business Wire
- 4 days ago - Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 days ago - Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026 - Business Wire
- 13 days ago - Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - Business Wire
- 14 days ago - Precision BioSciences Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 6 weeks ago - Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update - Business Wire
- 6 weeks ago - Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program - Business Wire